ORIC Pharmaceuticals Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jacob Chacko
Chief executive officer
US$3.2m
Total compensation
| CEO salary percentage | 18.9% |
| CEO tenure | 6yrs |
| CEO ownership | 1.1% |
| Management average tenure | 5yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
ORIC Pharmaceuticals: Mid-2024 Prostate Cancer Program Update Could Lead To Gains
Mar 13We're Not Very Worried About ORIC Pharmaceuticals' (NASDAQ:ORIC) Cash Burn Rate
Jan 18
We Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business Growth
Sep 27ORIC Pharmaceuticals (NASDAQ:ORIC) Is In A Good Position To Deliver On Growth Plans
Jun 14Companies Like ORIC Pharmaceuticals (NASDAQ:ORIC) Are In A Position To Invest In Growth
Jan 24ORIC Pharmaceuticals: Poster Child For The Current Downturn In Biotech
Oct 14Is ORIC Pharmaceuticals (NASDAQ:ORIC) In A Good Position To Deliver On Growth Plans?
Oct 08ORIC Pharmaceuticals GAAP EPS of -$0.51 beats by $0.09
Aug 11ORIC Pharmaceuticals (NASDAQ:ORIC) Is In A Good Position To Deliver On Growth Plans
Jun 24We're Hopeful That ORIC Pharmaceuticals (NASDAQ:ORIC) Will Use Its Cash Wisely
Mar 08We Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business Growth
Nov 23We Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business Growth
Aug 05ORIC Pharmaceuticals EPS beats by $0.04
May 06Here's Why We're Not Too Worried About ORIC Pharmaceuticals' (NASDAQ:ORIC) Cash Burn Situation
Apr 16We're Hopeful That ORIC Pharmaceuticals (NASDAQ:ORIC) Will Use Its Cash Wisely
Jan 01
Oric Pharma starts expansion phase of mid-stage solid tumor study with ORIC-101
Dec 21Oric Pharma prices stock offering at $23
Nov 13CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$3m | US$596k | -US$101m |
| Sep 30 2023 | n/a | n/a | -US$93m |
| Jun 30 2023 | n/a | n/a | -US$93m |
| Mar 31 2023 | n/a | n/a | -US$90m |
| Dec 31 2022 | US$4m | US$572k | -US$89m |
| Sep 30 2022 | n/a | n/a | -US$91m |
| Jun 30 2022 | n/a | n/a | -US$85m |
| Mar 31 2022 | n/a | n/a | -US$85m |
| Dec 31 2021 | US$7m | US$536k | -US$79m |
| Sep 30 2021 | n/a | n/a | -US$84m |
| Jun 30 2021 | n/a | n/a | -US$91m |
| Mar 31 2021 | n/a | n/a | -US$81m |
| Dec 31 2020 | US$6m | US$489k | -US$74m |
| Sep 30 2020 | n/a | n/a | -US$54m |
| Jun 30 2020 | n/a | n/a | -US$35m |
| Mar 31 2020 | n/a | n/a | -US$30m |
| Dec 31 2019 | US$672k | US$456k | -US$27m |
| Dec 31 2018 | US$2m | US$290k | -US$21m |
Compensation vs Market: Jacob's total compensation ($USD3.15M) is above average for companies of similar size in the US market ($USD2.41M).
Compensation vs Earnings: Jacob's compensation has been consistent with company performance over the past year.
CEO
Jacob Chacko (44 yo)
6yrs
Tenure
US$3,153,083
Compensation
Dr. Jacob M. Chacko, M.D., MBA, has been Chief Executive Officer and Director of ORIC Pharmaceuticals, Inc. since May 2018 and has been its President since May 2019. Dr. Chacko joined the ORIC Pharmaceutic...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 9.2yrs | US$186.87k | 0.34% $ 2.0m | |
| President | 6yrs | US$3.15m | 1.08% $ 6.4m | |
| Chief Financial Officer | 4.7yrs | US$1.45m | 0.12% $ 740.0k | |
| Chief Medical Officer | 5.7yrs | US$1.51m | 0.035% $ 210.2k | |
| Co-Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Co-Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Chief Scientific Officer | 4.8yrs | no data | no data | |
| General Counsel | 4.1yrs | no data | no data | |
| VP & Head of People | 1.7yrs | no data | no data | |
| Senior Vice President of Clinical Development | 5.2yrs | no data | no data | |
| Chief Business Officer | 5.5yrs | no data | no data |
5.0yrs
Average Tenure
56yo
Average Age
Experienced Management: ORIC's management team is seasoned and experienced (5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 9.2yrs | US$186.87k | 0.34% $ 2.0m | |
| President | 6yrs | US$3.15m | 1.08% $ 6.4m | |
| Co-Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Co-Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2.5yrs | US$140.37k | 0% $ 0 | |
| Independent Director | 3.9yrs | US$133.87k | 0% $ 0 | |
| Independent Director | 4.3yrs | US$147.87k | 0% $ 0 | |
| Indepdnent Director | 2.8yrs | US$141.37k | 0% $ 0 |
4.1yrs
Average Tenure
61.5yo
Average Age
Experienced Board: ORIC's board of directors are considered experienced (4.1 years average tenure).